Follow on Google News News By Tag Industry News * Medical device * More Industries... News By Place Country(s) Industry News
Follow on Google News | EBI to Host Investment in Innovation (IN³) Medical Device 360° Orlando Conference, Feb. 29-Mar 2EBI, publisher of “The Gray Sheet,” announces the program for its upcoming IN³ Medical Device 360° Conference, being held February 29 - March 2, 2012 at the Ritz-Carlton Orlando, Grande Lakes luxury resort in Orlando, Florida.
By: Kristy Kennedy Start-ups presenting in Orlando are developing exceptional technologies addressing the following diagnostic and therapeutic device markets, among many others: molecular diagnostics, nanotechnology, bioabsorbable implants, polymer technology, imaging, asthma, cancer, diabetes, glaucoma, ophthalmology, urology, organ transplantation, and pain management. Presenters confirmed to date include Alfa Thermodiagnostics, Inc., Axial Biotech Inc., Brainsway, Enox BioPharma Inc., Health-Chem Diagnostics, Implandata Ophthalmic Products GmbH, Juneau Biosciences, Magneceutical Health, Nano Interface Technology Inc., NinePoint Medical Inc., PCAsso Diagnostics LLC, Peytant Solutions, Inc., Poiesis Medical LLC, Sensimed AG, Smart Perfusion LLC, SpiroSure Inc., Surgical Innovations LLC and Vantix Ltd., among many others being added to the program regularly. Interactive and timely sessions taking place at IN³ Medical Device 360° Orlando include a pre-conference workshop, "Reimbursement Basics: What You Need to Know to Answer Investor Questions," presented by Kelli Hallas, Executive Vice President of Reimbursement, Emerson Consultants; Senior-level investment and business development executives participating in Orlando include Gary Brothers, Sr. Corporate Development Director, Medtronic, Inc.; Dennis Crowley, VP, Corporate Development, Covidien; William Marshall, VP, Strategy & Business Development, BD Medical; Peter Shagory, Partner, Baird Venture Partners; Aftab R. Kherani, Principal, Aisling Capital; Thomas Weldon, Managing Partner and Founder, Accuitive Medical Ventures; Scott Weiner, Transactional Partner, Pappas Ventures; Gerry Brunk, Managing Director, Lumira Capital; Mike Bunker, Managing Director, Early Stage Partners; Anya Schiess, Principal, Thomas McNerney & Partners; Ken Massey, Managing Director, LifeLine Ventures; and Don Urbanowicz, Principal, Urbanowicz Consulting, among many others. If your emerging company would like to apply to present in Orlando, please contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged. IN³ Medical Device 360° Orlando will be held at the Ritz-Carlton Orlando, Grande Lakes luxury resort, located on a picturesque 18-hole Greg Norman Signature Golf Course, that also features a 40,000-square- About Elsevier Business Intelligence Elsevier Business Intelligence (EBI) is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) CONTACT: Kayleen Kell Associate Account Manager Phone: 1-949-797-7142 1-855-202-5939 toll-free in the USA Email: k.kell@elsevier.com Web: www.in3orlando.com # # # Elsevier Business Intelligence (EBI) is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|